top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Align Technology Appoints Jennifer L. Davis as CEO, Succeeding Joseph Hogan Effective December 31, 2026

2 hours ago

1 min read

Tempe, AZ, October 28, 2026 (Business Wire) -- Align Technology, Inc. (NASDAQ: ALGN), a global medical device company specializing in digital orthodontics and restorative dentistry, has appointed Jennifer L. Davis as its next President and Chief Executive Officer, effective December 31, 2026. Davis will succeed Joseph M. Hogan, who has served as CEO since 2015 and will step down from the role at year-end before retiring from the Board of Directors in June 2027.

Read full article here.

Recent Posts

Setara Biosciences Raises $90M in Series A Financing to Advance Precision Medicines for Rare Genetic Diseases

San Diego, CA, October 30, 2026 (Business Wire) -- Setara Biosciences, a biotechnology company focused on developing precision medicines for rare genetic diseases, has announced a $90 million Series

Anavex Life Sciences Appoints Terrie Kellmeyer, Ph.D., as Permanent President and CEO to Lead Clinical Development Strategy

New York, NY, November 3, 2026 (Yahoo Finance) -- Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system (C

Rockwell Medical to Acquire Vantive’s Global Hemodialysis Business for $125M in Contingent Payments

Wixom, MI, November 3, 2026 (Business Wire) -- Rockwell Medical, Inc. (NASDAQ: RMTI) has entered into a definitive agreement to acquire Vantive Limited’s in-center hemodialysis business across 35 ju

Comments

Life Science Headlines

Setara Biosciences Raises $90M in Series A Financing to Advance Precision Medicines for Rare Genetic Diseases

Anavex Life Sciences Appoints Terrie Kellmeyer, Ph.D., as Permanent President and CEO to Lead Clinical Development Strategy

Rockwell Medical to Acquire Vantive’s Global Hemodialysis Business for $125M in Contingent Payments

Align Technology Appoints Jennifer L. Davis as CEO, Succeeding Joseph Hogan Effective December 31, 2026

Dren Bio Raises $350M in Private Financing to Advance Rare Blood Cancer Treatment Toward Commercialization

Alaunos Therapeutics Acquires Velaris Therapeutics and Raises $350M to Advance Pulmonary Hypertension Pipeline

AngioDynamics Appoints Eric Honroth as President and CEO Following Planned Leadership Transition

Stryker Invests $400M in CMR Surgical to Advance Robotic-Assisted Surgery

Harmony Biosciences Appoints Peter Anastasiou as CEO as Jeffrey Dayno Plans Retirement

STERIS to Acquire Xodus Medical for $2.1B to Expand Surgical Consumables Portfolio

bottom of page